Quizartinib is a drug for the treatment of specific leukemias, which has attracted widespread attention in the international medical field. This article will conduct an in-depth discussion on the details of the instructions for Quizartinib, the medical insurance and price status, and its efficacy and side effects.
Quizartinib instructions
The instructions for Quizartinib are the cornerstone of understanding the drug, and record its basic information, usage, dosage, and precautions in detail, providing guidance for patients to use the drug.
Basic information and indications
Quizartinib is mainly used to treat relapsed or refractory FLT3-ITD mutation-positive acute myeloid leukemia, and is a breakthrough drug granted by the US FDA.
Usage, dosage and dosage form
The drug exists in the form of tablets, which are white film-coated tablets. It is usually taken orally by adults once a day, with a starting dose of 26.5 mg, which increases to 53 mg after two weeks. The dosage needs to be adjusted according to the patient's condition.
Precautions and special populations
When using Quizartinib, you need to pay attention to adverse reactions such as QT interval prolongation and bone marrow suppression, and perform regular electrocardiogram and blood routine examinations. Special populations such as pregnant women, breastfeeding women, children and the elderly should be cautious when using it and follow specific guidelines.
The instructions for use of Quizartinib comprehensively explain the characteristics of the drug, provide a scientific basis for clinical medication, and help patients receive treatment effectively.
Quizartinib medical insurance, price
The price and medical insurance status of Quizartinib directly affect the patient's economic burden and treatment options, which is a common concern of patients.
Price Overview
The Indian version of Quizartinib is 17.7mg/box, and imported drugs have relatively high costs.
Medical insurance status
Currently, patients need to pay for treatment at their own expense.
The high price of Quizartinib and the fact that it has not yet been included in medical insurance have brought economic pressure to patients, and it is urgent to explore more payment methods and channels to reduce the burden on patients.
Quizartinib efficacy, side effects
The efficacy and side effects of Quizartinib are key indicators to measure its therapeutic value, which are directly related to the patient's treatment effect and quality of life.
Efficacy
Quizatinib prolonged the survival rate of the FLT3-ITDAML mouse model in clinical trials by inhibiting FLT3 activity, demonstrating its strong therapeutic potential for specific leukemias.
Main side effects
Possible adverse reactions to the use of quizatinib include QT interval prolongation, thrombocytopenia, neutropenia, etc., which need to be closely monitored and treated in a timely manner.
Management and prevention
To reduce side effects, patients should follow the doctor's advice, perform regular electrocardiogram and blood routine tests, and adjust the dosage or stop the drug if necessary.
While quizatinib shows good efficacy, it is also accompanied by certain side effects. Through scientific management and prevention, its therapeutic value can be maximized.
